Rao, R.V., Hermel, E., Castro-Obregon, S., del Rio, G., Ellerby, L.M., Ellerby, H.M. and
Bredesen, D.E. (2001) Coupling endoplasmic reticulum stress to the cell death program.
Mechanism of caspase activation. J. Biol. Chem. 276: 33869–33874.
Raoul, C., Henderson, C.E. and Pettmann, B. (1999) Programmed cell death of embryonic
motoneurons triggered through the Fas death receptor. J.Cell Biol. 147:1049–1062.
Rasper, D.M., Vaillancourt, J.P., Hadano, S., et al. (1998) Cell death attenuation by Usurpin,
a mammalian DED-caspase homologue that precludes caspase-8 recruitment and
activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5:271–288.
Raveh, T., Droguett, G., Horwitz, M.S., DePinho, R.A. and Kimchi, A. (2001) DAP kinase
activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic
transformation. Nat. Cell. Biol. 3:1–7.
Ravi, R. and Bedi, A. (2002) Requirement of BAX for TRAIL/Apo2L-induced apoptosis of
colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res.
62:1583–1587.
Ravi, R., Bedi, A. and Fuchs, E.J. (1998a) CD95 (Fas)-induced caspase-mediated proteolysis
of NF-kappaB. Cancer Res. 58:882–886.
Ravi, R., Bedi, G.C., Engstrom, L.W., Zeng, Q., Mookerjee, B., Gelinas, C., Fuchs, E.J. and
Bedi, A. (2001) Regulation of death receptor expression and TRAIL/Apo2L-induced
apoptosis by NF-kappaB. Nat. Cell. Biol. 3:409–416.
Ravi, R., Mookerjee, B., van Hensbergen, Y., Bedi, G.C., Giordano, A., el Deiry, W.S.,
Fuchs, E.J. and Bedi, A. (1998b) p53-mediated repression of nuclear factor-kappaB RelA
via the transcriptional integrator p300. Cancer Res. 58: 4531–4536.
Reddien, P.W., Cameron, S. and Horvitz, H.R. (2001) Phagocytosis promotes programmed
cell death in C. elegans. Nature 412:198–202.
Reddien, P.W. and Horvitz, H.R. (2000) CED-2/CrkII and CED-10/Rac control
phagocytosis and cell migration in Caenorhabditis elegans. Nat. Cell. Biol. 2: 131–136.
Reimertz, C., Kogel, D., Lankiewicz, S., Poppe, M. and Prehn, J.H. (2001) Ca(2+)-induced
inhibition of apoptosis in human SH-SY5Y neuroblastoma cells: degradation of apoptotic
protease activating factor-1 (APAF-1) J. Neurochem. 78:1256–1266.
Reinheckel, T., Deussing, J., Roth, W. and Peters, C. (2001) Towards specific func-tions of
lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin
L. Biol. Chem. 382:735–741.
Renatus, M., Stennicke, H.R., Scott, F.L., Liddington, R.C. and Salvesen, G.S. (2001) Dimer
formation drives the activation of the cell death protease caspase 9. Proc. Natl Acad. Sci.
U.S.A. 98:14250–14255.
Renshaw, B.R., Fanslow, W.C., Iii, A.R.J., Campbell, K.A., Liggitt, D., Wright, B., Davison,
B.L. and Maliszewski, C.R. (1994) Humoral immune responses in CD40 ligand-deficient
mice. J.Exp. Med. 180:1889–1900.
Reuther, J.Y. and Baldwin, A.S., Jr. (1999) Apoptosis promotes a caspase-induced amino-
terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB.
J.Biol. Chem. 274:20664–20670.
Rhind, N. and Russell, P. (2000) Checkpoints: it takes more than time to heal some wounds.
Curr. Biol. 10: R908-R911.
Rich, T., Allen, R.L. and Wyllie, A.H. (2000) Defying death after DNA damage. Nature 407:
777–783.
Riddiford, L.M. (1993) Hormones and Drosophila development. In: The Development of
Drosophila melanogaster, vol. II (eds M.Bate and A.Martinez Arias). Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, pp. 899–939.
REFERENCES 281